Jun-Qiang Si
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jun-Qiang Si has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Li Li
Department of Physiology, Medical College of Jiaxing University, Jiaxing, Zhejiang, 314000, China
28 shared publications Ke-Tao Ma
Department of Physiology, Shihezi University School of Medicine, Shihezi, China
16 shared publicationsYang Wang
Department of Physiology, The Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University Medical College, Shihezi, China
12 shared publicationsLi Li
Department of Physiology, Medical College of Jiaxing University, Jiaxing, China
9 shared publicationsNan Cao
Department of Physiology, Kangda College of Nanjing Medical University, Lianyungang, China
9 shared publicationsChao-Yang Tan
Department of Physiology, Shihezi University Medical College, Shihezi, Xinjiang 832002, P.R. China
6 shared publications
Latest Publications
- 8 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 795, 153090
The role of Drp1-Pink1-Parkin mediated mitophagy in cisplatin-induced damage to primary cochlear SV pericytes
- 8 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 795, 153090
The role of Drp1-Pink1-Parkin mediated mitophagy in cisplatin-induced damage to primary cochlear SV pericytes
- Open Access
- 1 September 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 4687-4698
Circadian Rhythms and Pain: A Narrative Review on Clock Genes and Circadian-Based Interventions
Pain is a common symptom of many diseases and seriously affects the quality of life. Circadian rhythm is the regular, cyclical physiological, biochemical, and behavioral changes that occur within a 24-hour period in biological organisms, primarily regulated by clock genes. Pain sensitivity may have circadian rhythms, with clock genes likely influencing this pain-related rhythmicity. Therefore, restoring normal circadian rhythms and regulating the expression of clock genes are regarded as viable strategies to combat the development of pain. First, this review elucidates the core operational mechanisms of clock genes. Second, it also discusses the relationship among multiple types of pain and clock genes, such as sciatic nerve injury, inflammatory pain, chemotherapy-induced neuropathic pain, headache, the pain of Restless Legs Syndrome and fibromyalgia. Third, it presents the pain treatment and pain management strategies based on the current research on circadian rhythms. Exploring the role of circadian rhythm in pain can help increase our understanding of pain and have significant clinical implications for pain patients. Plain Language Summary: The core of the circadian rhythm is driven by genes such as Per, Cry, Bmal1, Clock, Npas2 and Rev-erbα, and abnormal expression of these genes is directly associated with sciatic nerve injury, inflammatory pain, chemotherapy-induced neuropathic pain, headache, the pain of Restless Legs Syndrome and fibromyalgia. This study focuses on the mechanisms of the circadian rhythm, the relationship between clock genes and pain, as well as the applications of the circadian rhythm in pain management and treatment. Pain can be alleviated through chronotherapy, clock gene-based therapies and Traditional Chinese Medicine to regulate clock genes and suppress inflammatory factors. Future research on circadian rhythms and pain may provide more comprehensive solutions for pain management and treatment.
- 1 September 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 4687-4698
Open AccessCircadian Rhythms and Pain: A Narrative Review on Clock Genes and Circadian-Based Interventions
Pain is a common symptom of many diseases and seriously affects the quality of life. Circadian rhythm is the regular, cyclical physiological, biochemical, and behavioral changes that occur within a 24-hour period in biological organisms, primarily regulated by clock genes. Pain sensitivity may have circadian rhythms, with clock genes likely influencing this pain-related rhythmicity. Therefore, restoring normal circadian rhythms and regulating the expression of clock genes are regarded as viable strategies to combat the development of pain. First, this review elucidates the core operational mechanisms of clock genes. Second, it also discusses the relationship among multiple types of pain and clock genes, such as sciatic nerve injury, inflammatory pain, chemotherapy-induced neuropathic pain, headache, the pain of Restless Legs Syndrome and fibromyalgia. Third, it presents the pain treatment and pain management strategies based on the current research on circadian rhythms. Exploring the role of circadian rhythm in pain can help increase our understanding of pain and have significant clinical implications for pain patients. Plain Language Summary: The core of the circadian rhythm is driven by genes such as Per, Cry, Bmal1, Clock, Npas2 and Rev-erbα, and abnormal expression of these genes is directly associated with sciatic nerve injury, inflammatory pain, chemotherapy-induced neuropathic pain, headache, the pain of Restless Legs Syndrome and fibromyalgia. This study focuses on the mechanisms of the circadian rhythm, the relationship between clock genes and pain, as well as the applications of the circadian rhythm in pain management and treatment. Pain can be alleviated through chronotherapy, clock gene-based therapies and Traditional Chinese Medicine to regulate clock genes and suppress inflammatory factors. Future research on circadian rhythms and pain may provide more comprehensive solutions for pain management and treatment.
- Open Access
- 4 October 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-16
Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway
Pulmonary arterial hypertension (PAH) is a worldwide challenging disease characterized by progressive elevation of pulmonary artery pressure. The proliferation, migration and phenotypic transformation of pulmonary smooth muscle cells are the key steps of pulmonary vascular remodeling. Quercetin (3,3', 4', 5, 6-pentahydroxyflavone, Que) is a natural flavonol compound that has antioxidant, anti-inflammatory, anti-tumor and other biological activities. Studies have shown that Que has therapeutic effects on PAH. However, the effect of quercetin on pulmonary vascular remodeling in PAH and its mechanism remain unclear. In vivo, PAH rats were constructed by intraperitoneal injection of monocrotaline (MCT) at 60 mg/kg. Human pulmonary artery smooth muscle cells (HPASMCs) were treated with platelet-derived growth factor BB (PDGF-BB) 20 ng/mL to construct PAH cell model in vitro. The results showed that in vivo studies, MCT could induce right ventricular wall hyperplasia, narrow the small and medium pulmonary artery cavity, up-regulate the expression of proliferating and migration-related proteins proliferating cell nuclear antigen (PCNA) and osteopontin (OPN), and down-regulate the expression of alpha-smooth muscle actin (α-SMA). Que reversed the MCT-induced results. This process works by down-regulating the transforming growth factor-β1 (TGF-β1)/ Smad2/3 signaling pathway. In vitro studies, Que had the same effect on PDGF-BB-induced proliferation and migration cell models. Que inhibits the proliferation, migration and phenotypic transformation of HPASMCs by down-regulating TGF-β1/Smad2/Smad3 pathway, thereby reducing right ventricular hyperplasia (RVH) and pulmonary vascular remodeling, providing potential pharmacological and molecular explanations for the treatment of PAH. (1) Que can significantly improve the hemodynamic changes, RVH and pulmonary vascular remodeling in MCT induced PAH rats. (2) Que inhibits the proliferation, migration and phenotypic transformation of HPASMCs by regulating TGF-β1/Smad2/Smad3 pathway, thus playing a protective role in PAH pulmonary vascular remodeling.
- 4 October 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-16
Open AccessQuercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway
Pulmonary arterial hypertension (PAH) is a worldwide challenging disease characterized by progressive elevation of pulmonary artery pressure. The proliferation, migration and phenotypic transformation of pulmonary smooth muscle cells are the key steps of pulmonary vascular remodeling. Quercetin (3,3', 4', 5, 6-pentahydroxyflavone, Que) is a natural flavonol compound that has antioxidant, anti-inflammatory, anti-tumor and other biological activities. Studies have shown that Que has therapeutic effects on PAH. However, the effect of quercetin on pulmonary vascular remodeling in PAH and its mechanism remain unclear. In vivo, PAH rats were constructed by intraperitoneal injection of monocrotaline (MCT) at 60 mg/kg. Human pulmonary artery smooth muscle cells (HPASMCs) were treated with platelet-derived growth factor BB (PDGF-BB) 20 ng/mL to construct PAH cell model in vitro. The results showed that in vivo studies, MCT could induce right ventricular wall hyperplasia, narrow the small and medium pulmonary artery cavity, up-regulate the expression of proliferating and migration-related proteins proliferating cell nuclear antigen (PCNA) and osteopontin (OPN), and down-regulate the expression of alpha-smooth muscle actin (α-SMA). Que reversed the MCT-induced results. This process works by down-regulating the transforming growth factor-β1 (TGF-β1)/ Smad2/3 signaling pathway. In vitro studies, Que had the same effect on PDGF-BB-induced proliferation and migration cell models. Que inhibits the proliferation, migration and phenotypic transformation of HPASMCs by down-regulating TGF-β1/Smad2/Smad3 pathway, thereby reducing right ventricular hyperplasia (RVH) and pulmonary vascular remodeling, providing potential pharmacological and molecular explanations for the treatment of PAH. (1) Que can significantly improve the hemodynamic changes, RVH and pulmonary vascular remodeling in MCT induced PAH rats. (2) Que inhibits the proliferation, migration and phenotypic transformation of HPASMCs by regulating TGF-β1/Smad2/Smad3 pathway, thus playing a protective role in PAH pulmonary vascular remodeling.
- Top Cited PapersOpen Access
- 2 August 2024
- Published by Taylor & Francis in Redox Report
- Vol. 29 (1) , 2382943
Hyperglycemia-induced oxidative stress exacerbates mitochondrial apoptosis damage to cochlear stria vascularis pericytes via the ROS-mediated Bcl-2/CytC/AIF pathway
Diabetes is closely linked to hearing loss, yet the exact mechanisms remain unclear. Cochlear stria vascularis and pericytes (PCs) are crucial for hearing. This study investigates whether high glucose induces apoptosis in the cochlear stria vascularis and pericytes via elevated ROS levels due to oxidative stress, impacting hearing loss. We established a type II diabetes model in C57BL/6J mice and used auditory brainstem response (ABR), Evans blue staining, HE staining, immunohistochemistry, and immunofluorescence to observe changes in hearing, blood-labyrinth barrier (BLB) permeability, stria vascularis morphology, and apoptosis protein expression. Primary cultured stria vascularis pericytes were subjected to high glucose, and apoptosis levels were assessed using flow cytometry, Annexin V-FITC, Hoechst 33342 staining, Western blot, Mitosox, and JC-1 probes. Diabetic mice showed decreased hearing thresholds, reduced stria vascularis density, increased oxidative stress, cell apoptosis, and decreased antioxidant levels. High glucose exposure increased apoptosis and ROS content in pericytes, while mitochondrial membrane potential decreased, with AIF and cytochrome C (CytC) released from mitochondria to the cytoplasm. Adding oxidative scavengers reduced AIF and CytC release, decreasing pericyte apoptosis. Hyperglycemia may induce mitochondrial apoptosis of cochlear stria vascularis pericytes through oxidative stress.
- 2 August 2024
- Published by Taylor & Francis in Redox Report
- Vol. 29 (1) , 2382943
Top Cited PapersOpen AccessHyperglycemia-induced oxidative stress exacerbates mitochondrial apoptosis damage to cochlear stria vascularis pericytes via the ROS-mediated Bcl-2/CytC/AIF pathway
Diabetes is closely linked to hearing loss, yet the exact mechanisms remain unclear. Cochlear stria vascularis and pericytes (PCs) are crucial for hearing. This study investigates whether high glucose induces apoptosis in the cochlear stria vascularis and pericytes via elevated ROS levels due to oxidative stress, impacting hearing loss. We established a type II diabetes model in C57BL/6J mice and used auditory brainstem response (ABR), Evans blue staining, HE staining, immunohistochemistry, and immunofluorescence to observe changes in hearing, blood-labyrinth barrier (BLB) permeability, stria vascularis morphology, and apoptosis protein expression. Primary cultured stria vascularis pericytes were subjected to high glucose, and apoptosis levels were assessed using flow cytometry, Annexin V-FITC, Hoechst 33342 staining, Western blot, Mitosox, and JC-1 probes. Diabetic mice showed decreased hearing thresholds, reduced stria vascularis density, increased oxidative stress, cell apoptosis, and decreased antioxidant levels. High glucose exposure increased apoptosis and ROS content in pericytes, while mitochondrial membrane potential decreased, with AIF and cytochrome C (CytC) released from mitochondria to the cytoplasm. Adding oxidative scavengers reduced AIF and CytC release, decreasing pericyte apoptosis. Hyperglycemia may induce mitochondrial apoptosis of cochlear stria vascularis pericytes through oxidative stress.
- 22 November 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 690, 149257
The effects of noise exposure on hippocampal cognition in C57BL/6 mice via transcriptomics
- 22 November 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 690, 149257
The effects of noise exposure on hippocampal cognition in C57BL/6 mice via transcriptomics
- 31 October 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 687, 149172
PGC-1α affects cochlear pericytes migration in noise-exposed mice
- 31 October 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 687, 149172
PGC-1α affects cochlear pericytes migration in noise-exposed mice
- 27 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 681, 283-290
Noise exposure increase apoptosis in the hippocampus of AD mice through the upregulation of CTSS
- 27 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 681, 283-290
Noise exposure increase apoptosis in the hippocampus of AD mice through the upregulation of CTSS
- Open Access
- 9 December 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (24) , 12628
High-Efficiency Adsorption of SARS-CoV-2 Spike 1 Protein by Plasma-Modified Porous Polymers
Under the background of the COVID-19 pandemic, this study reports an affordable and easily prepared porous material modified by nanosecond-pulsed discharge plasma, which can adsorb SARS-CoV-2 S1 protein efficiently. Both Western blotting and an enzyme-linked immunosorbent assay were used to detect the adsorption efficiency of SARS-CoV-2 S1 protein. The physical and chemical properties of the modified porous polymer were characterized by scanning electron microscopy, X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy. We found that the new type of porous polymer material presented an excellent performance on SARS-CoV-2 S1 protein adsorption, whose adsorption efficiency reached 99.99% in 1 min. Both the physical and chemical characterizations showed that the material has many fresh pores on the material surface and that the surface is implanted with polar functional groups (C−O, C=O, O−C=O and −NH), which gives the material a high chemisorption performance along with an enhanced physical adsorption performance. Notably, the material can be prepared at prices ranging in the tens of dollars per kilogram, which shows that it could have great applications for respiratory virus protection in global epidemic states.
- 9 December 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (24) , 12628
Open AccessHigh-Efficiency Adsorption of SARS-CoV-2 Spike 1 Protein by Plasma-Modified Porous Polymers
Under the background of the COVID-19 pandemic, this study reports an affordable and easily prepared porous material modified by nanosecond-pulsed discharge plasma, which can adsorb SARS-CoV-2 S1 protein efficiently. Both Western blotting and an enzyme-linked immunosorbent assay were used to detect the adsorption efficiency of SARS-CoV-2 S1 protein. The physical and chemical properties of the modified porous polymer were characterized by scanning electron microscopy, X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy. We found that the new type of porous polymer material presented an excellent performance on SARS-CoV-2 S1 protein adsorption, whose adsorption efficiency reached 99.99% in 1 min. Both the physical and chemical characterizations showed that the material has many fresh pores on the material surface and that the surface is implanted with polar functional groups (C−O, C=O, O−C=O and −NH), which gives the material a high chemisorption performance along with an enhanced physical adsorption performance. Notably, the material can be prepared at prices ranging in the tens of dollars per kilogram, which shows that it could have great applications for respiratory virus protection in global epidemic states.
- 1 September 2022
- Vol. 38 (9) , 807-812
[Capsaicin inhibits proliferation and migration of cerebral basilar artery smooth muscle cells in spontaneously hypertensive rats].
Objective To investigate whether capsaicin (CAP) can improve the proliferation and migration of cerebral basilar artery smooth muscle cells (BASMCs) in spontaneously hypertensive rats (SHR). Methods Primary BASMCs of SHR and Wistar-Kyoto (WKY) rats were cultured in vitro, randomly divided into control group (WKY group), SHR group and capsaicin treatment group (CAP group). The intervention concentration of CAP was determined by CCK-8 assay; TranswellTM chamber assay and scratch test were used to detect the migration ability of BASMCs; the expression and distribution of osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) in BASMCs were detected by immunofluorescence assay, and Western blot analysis was used to detect the protein levels of OPN and PCNA in BASMCs. Results Compared with WKY group, the proliferation and migration ability of BASMC in SHR group were enhanced, while the CAP treatment undermined the proliferation and migration of BASMCs. OPN was expressed in the cytoplasm and nucleus of BASMCs, while PCNA was mainly expressed in the nuclei. Compared with WKY group, the expression and protein level of OPN and PCNA were increased in SHR group, and decreased significantly after CAP treatment. Conclusion Capsaicin can reduce the proliferation and migration of SHR derived BASMCs.
- 1 September 2022
- Vol. 38 (9) , 807-812
[Capsaicin inhibits proliferation and migration of cerebral basilar artery smooth muscle cells in spontaneously hypertensive rats].
Objective To investigate whether capsaicin (CAP) can improve the proliferation and migration of cerebral basilar artery smooth muscle cells (BASMCs) in spontaneously hypertensive rats (SHR). Methods Primary BASMCs of SHR and Wistar-Kyoto (WKY) rats were cultured in vitro, randomly divided into control group (WKY group), SHR group and capsaicin treatment group (CAP group). The intervention concentration of CAP was determined by CCK-8 assay; TranswellTM chamber assay and scratch test were used to detect the migration ability of BASMCs; the expression and distribution of osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) in BASMCs were detected by immunofluorescence assay, and Western blot analysis was used to detect the protein levels of OPN and PCNA in BASMCs. Results Compared with WKY group, the proliferation and migration ability of BASMC in SHR group were enhanced, while the CAP treatment undermined the proliferation and migration of BASMCs. OPN was expressed in the cytoplasm and nucleus of BASMCs, while PCNA was mainly expressed in the nuclei. Compared with WKY group, the expression and protein level of OPN and PCNA were increased in SHR group, and decreased significantly after CAP treatment. Conclusion Capsaicin can reduce the proliferation and migration of SHR derived BASMCs.
- Open Access
- 20 July 2022
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 50 (3) , 1-13
Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration
The investigation of effective therapeutic drugs for pulmonary hypertension (PH) is critical. KIR2.1 plays crucial roles in regulating cell proliferation and migration, and vascular remodeling. However, researchers have not yet clearly determined whether KIR2.1 participates in the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) and its role in pulmonary vascular remodeling (PVR) also remains elusive. The present study aimed to examine whether KIR2.1 alters PASMC proliferation and migration, and participates in PVR, as well as to explore its mechanisms of action. For the in vivo experiment, a PH model was established by intraperitoneally injecting Sprague‑Dawley rats monocrotaline (MCT). Hematoxylin and eosin staining revealed evidence of PVR in the rats with PH. Immunofluorescence staining and western blot analysis revealed increased levels of the KIR2.1, osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) proteins in pulmonary blood vessels and lung tissues following exposure to MCT, and the TGF‑β1/SMAD2/3 signaling pathway was activated. For the in vitro experiments, the KIR2.1 inhibitor, ML133, or the TGF‑β1/SMAD2/3 signaling pathway blocker, SB431542, were used to pre‑treat human PASMCs (HPASMCs) for 24 h, and the cells were then treated with platelet‑derived growth factor (PDGF)‑BB for 24 h. Scratch and Transwell assays revealed that PDGF‑BB promoted cell proliferation and migration. Immunofluorescence staining and western blot analysis demonstrated that PDGF‑BB upregulated OPN and PCNA expression, and activated the TGF‑β1/SMAD2/3 signaling pathway. ML133 reversed the proliferation and migration induced by PDGF‑BB, inhibited the expression of OPN and PCNA, inhibited the TGF‑β1/SMAD2/3 signaling pathway, and reduced the proliferation and migration of HPASMCs. SB431542 pre‑treatment also reduced cell proliferation and migration; however, it did not affect KIR2.1 expression. On the whole, the results of the present study demonstrate that KIR2.1 regulates the TGF‑β1/SMAD2/3 signaling pathway and the expression of OPN and PCNA proteins, thereby regulating the proliferation and migration of PASMCs and participating in PVR.
- 20 July 2022
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 50 (3) , 1-13
Open AccessInhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration
The investigation of effective therapeutic drugs for pulmonary hypertension (PH) is critical. KIR2.1 plays crucial roles in regulating cell proliferation and migration, and vascular remodeling. However, researchers have not yet clearly determined whether KIR2.1 participates in the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) and its role in pulmonary vascular remodeling (PVR) also remains elusive. The present study aimed to examine whether KIR2.1 alters PASMC proliferation and migration, and participates in PVR, as well as to explore its mechanisms of action. For the in vivo experiment, a PH model was established by intraperitoneally injecting Sprague‑Dawley rats monocrotaline (MCT). Hematoxylin and eosin staining revealed evidence of PVR in the rats with PH. Immunofluorescence staining and western blot analysis revealed increased levels of the KIR2.1, osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) proteins in pulmonary blood vessels and lung tissues following exposure to MCT, and the TGF‑β1/SMAD2/3 signaling pathway was activated. For the in vitro experiments, the KIR2.1 inhibitor, ML133, or the TGF‑β1/SMAD2/3 signaling pathway blocker, SB431542, were used to pre‑treat human PASMCs (HPASMCs) for 24 h, and the cells were then treated with platelet‑derived growth factor (PDGF)‑BB for 24 h. Scratch and Transwell assays revealed that PDGF‑BB promoted cell proliferation and migration. Immunofluorescence staining and western blot analysis demonstrated that PDGF‑BB upregulated OPN and PCNA expression, and activated the TGF‑β1/SMAD2/3 signaling pathway. ML133 reversed the proliferation and migration induced by PDGF‑BB, inhibited the expression of OPN and PCNA, inhibited the TGF‑β1/SMAD2/3 signaling pathway, and reduced the proliferation and migration of HPASMCs. SB431542 pre‑treatment also reduced cell proliferation and migration; however, it did not affect KIR2.1 expression. On the whole, the results of the present study demonstrate that KIR2.1 regulates the TGF‑β1/SMAD2/3 signaling pathway and the expression of OPN and PCNA proteins, thereby regulating the proliferation and migration of PASMCs and participating in PVR.